Alfred E. Tiefenbacher GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alfred E. Tiefenbacher GmbH & Co KG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10543
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alfred E. Tiefenbacher GmbH & Co KG (AET) is an independent pharmaceutical company that focuses on the development of active pharmaceuticals ingredients. It offers products in the forms of tablets, capsules, oral solution, patches, long acting injectables, ophthalmic solution and inhaled therapies. The company develops and supply finished dosage form (FDF) generic pharmaceuticals to marketing organizations internationally. AET also provides services such as active pharmaceutical ingredient (API) sourcing; clinical trials; quality assurance; registration; supply chain; marketing and sales; and intellectual property services. The company operates in India, Cyprus, Malta, China and the US. AET is headquartered in Hamburg, Germany.

Alfred E. Tiefenbacher GmbH & Co KG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Alfred E. Tiefenbacher Receives Technology of Pramipexole from Hyundai Pharmaceutical 10
Alfred E. Tiefenbacher Forms Joint Venture with Combino Pharm 11
AET BioTechnologie Enters Into Co-Development Agreement With BioXpress Therapeutics For Adalimumab Biosimilar 12
Licensing Agreements 13
Hyundai Pharm Enters Into Licensing Agreement With Alfred E. Tiefenbacher For Pramipexole SR 13
Alfred E. Tiefenbacher GmbH & Co KG – Key Competitors 14
Alfred E. Tiefenbacher GmbH & Co KG – Key Employees 15
Alfred E. Tiefenbacher GmbH & Co KG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Key Facts 2
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfred E. Tiefenbacher GmbH & Co KG, Deals By Therapy Area, 2012 to YTD 2018 8
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alfred E. Tiefenbacher Receives Technology of Pramipexole from Hyundai Pharmaceutical 10
Alfred E. Tiefenbacher Forms Joint Venture with Combino Pharm 11
AET BioTechnologie Enters Into Co-Development Agreement With BioXpress Therapeutics For Adalimumab Biosimilar 12
Hyundai Pharm Enters Into Licensing Agreement With Alfred E. Tiefenbacher For Pramipexole SR 13
Alfred E. Tiefenbacher GmbH & Co KG, Key Competitors 14
Alfred E. Tiefenbacher GmbH & Co KG, Key Employees 15
Alfred E. Tiefenbacher GmbH & Co KG, Other Locations 16
Alfred E. Tiefenbacher GmbH & Co KG, Subsidiaries 16
Alfred E. Tiefenbacher GmbH & Co KG, Joint Venture 16

List of Figures
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfred E. Tiefenbacher GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Alfred E. Tiefenbacher GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Toyota Motor Corp (7203):電力:M&Aディール及び事業提携情報
    Summary Toyota Motor Corp (Toyota) is a manufacturer of automobiles. It designs, manufactures, assembles and sells passenger cars, minivans, recreational and sport-utility vehicles, commercial vehicles such as trucks and related parts and accessories. It also manufactures crafts, and finances its de …
  • Massachusetts General Hospital-医療機器分野:企業M&A・提携分析
    Summary Massachusetts General Hospital (MGH) is a healthcare service provider which offers diagnostic and therapeutic care services. The hospital provides services such as allergy and immunology; ALS multidisciplinary clinic, anesthesia, critical care and pain medicine; back bay healthcare center, b …
  • Suntory Beverage & Food Limited:企業の戦略・SWOT・財務情報
    Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report Summary Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • North China Pharmaceutical Group Corp-製薬・医療分野:企業M&A・提携分析
    Summary North China Pharmaceutical Group Corp (NCPC) is a healthcare products provider that manufactures and distributes antibiotic bulks and formulations, vitamins and nutrition products. The company’s products comprise antibiotics, penicillin, amoxicillin, streptomycin sulfate, cefradine, 7-ADCA, …
  • WesternZagros Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary WesternZagros Resources ULC (WesternZagros), formerly WesternZagros Resources Ltd, a subsidiary of Crest Energy International Ltd, is an oil and gas company that acquires, develops, explores and produces crude oil and natural gas. The company holds production sharing contracts with the Kurdi …
  • Extraction Oil & Gas Inc (XOG):企業の財務・戦略的SWOT分析
    Extraction Oil & Gas Inc (XOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • The InterTech Group Inc:企業の戦略的SWOT分析
    The InterTech Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Ajinomoto Co., Inc.:企業の戦略・SWOT・財務情報
    Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • SynDevRx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SynDevRx Inc (SDX) is a drug development company that develops treatments for cancer and metabolic dysfunction. The company offers lead compound SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active novel small molecule fumagillol derivative in vivo. Its servic …
  • Walchandnagar Industries Ltd
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DiaGenic ASA (NEL)-医療機器分野:企業M&A・提携分析
    Summary DiaGenic ASA (DiaGenic) is a medical device company that develops innovative in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from th …
  • United States Endoscopy Group Inc:企業の戦略的SWOT分析
    United States Endoscopy Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析
    Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Medusa Mining Ltd:企業の戦略・SWOT・財務分析
    Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hang Seng Bank Ltd:企業の戦略・SWOT・財務情報
    Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tutunski Kombinat AD Prilep:企業の戦略・SWOT・財務分析
    Tutunski Kombinat AD Prilep - Strategy, SWOT and Corporate Finance Report Summary Tutunski Kombinat AD Prilep - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Medigus Ltd (MDGS):医療機器:M&Aディール及び事業提携情報
    Summary Medigus Ltd (Medigus) is a medical device company that develops minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The company’s muse system enables endoscopists to treat gastroesophageal reflux disease (GERD) by performing fundoplication …
  • Toyota Tsusho Corporation:企業の戦略・SWOT・財務分析
    Toyota Tsusho Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Tsusho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dongwon F&B Co., Ltd.:企業の戦略・SWOT・財務情報
    Dongwon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dongwon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • DiaCarta Inc-医療機器分野:企業M&A・提携分析
    Summary DiaCarta Inc (DiaCarta) develops and commercializes molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆